share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.

辉瑞 | 4:持股变动声明-高管 DAMICO JENNIFER B.
美股sec公告 ·  05/01 15:42
Moomoo AI 已提取核心信息
Jennifer B. D'Amico, SVP & Controller of Pfizer Inc. (PFE), has engaged in a transaction involving the company's stock on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action type and status, as well as the number of shares held by D'Amico after the transaction, are also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Jennifer B. D'Amico, SVP & Controller of Pfizer Inc. (PFE), has engaged in a transaction involving the company's stock on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action type and status, as well as the number of shares held by D'Amico after the transaction, are also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
辉瑞公司(PFE)高级副总裁兼财务总监詹妮弗·达米科于2024年4月30日参与了一项涉及该公司股票的交易。该交易的具体细节,包括股票数量、交易价格和总价值,尚未在提供的公告中披露。交易类型和状态以及D'Amico在交易后持有的股票数量也未提供。建议投资者寻求更多信息,以充分了解这一事件对其投资决策的影响。
辉瑞公司(PFE)高级副总裁兼财务总监詹妮弗·达米科于2024年4月30日参与了一项涉及该公司股票的交易。该交易的具体细节,包括股票数量、交易价格和总价值,尚未在提供的公告中披露。交易类型和状态以及D'Amico在交易后持有的股票数量也未提供。建议投资者寻求更多信息,以充分了解这一事件对其投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息